Spyre Therapeutics (SYRE) Return on Capital Employed Growth (5y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Spyre Therapeutics | 5.55 Bn | 5.55 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,253.00 |
| Dec 31, 2025 | 2,133.00 |
| Sep 30, 2025 | 884.00 |
| Jun 30, 2025 | 3,719.00 |
| Mar 31, 2025 | 10,238.00 |
| Dec 31, 2024 | 6,436.00 |
| Sep 30, 2024 | 2,686.00 |
| Jun 30, 2024 | 2,251.00 |
| Mar 31, 2024 | -1,285.00 |
| Dec 31, 2023 | -2,915.00 |
| Sep 30, 2023 | -6,529.00 |
| Jun 30, 2023 | 31,192.00 |
| Mar 31, 2023 | -9,826.00 |
| Dec 31, 2022 | -7,455.00 |
| Sep 30, 2022 | -6,054.00 |
| Jun 30, 2022 | -6,914.00 |
| Mar 31, 2022 | -5,026.00 |
| Dec 31, 2021 | -3,268.00 |
| Sep 30, 2021 | -2,907.00 |
| Jun 30, 2021 | -1,593.00 |
| Mar 31, 2021 | -2,163.00 |